This statement is interesting . FDA approved vp in 2016! Should be ema approved for epp- close enough
Ann: SCENESSE European Orphan Drug Designation for VP, page-5
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.75 |
Change
0.060(0.44%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| $13.70 | $13.87 | $13.69 | $210.0K | 15.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 116 | $13.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.75 | 119 | 9 |
View Market Depth
| Last trade - 11.59am 14/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |